Trial Site Detail

 

Drug:
Nilotinib
Trial:
Efficacy and Safety of AMN107 Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib - Extension
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Karmanos Cancer Institute

4100 John R     
Detroit , MI 48201
USA

 

Principal Investigator:
Contact:
all (800) KARMANOS (1-800-527-6266) or e-mail info@karmanos.org.
Activation Status of this Site:
Closed
Notes about this Site:
Karmanos Cancer Institute Website:
https://app-oncoreprod1.karmanos.org/sip/SIPControlServlet

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.